Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Volberding

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|April 15, 1990
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesP A Volberding, S W Lagakos, M A Koch, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
The Journal of Infectious Diseases|April 1, 1986
Serological characterization of HTLV-III infection in AIDS and related disordersJ E Groopman, F W Chen, J A Hope, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complexT L Hodges, J O Kahn, L D Kaplan, et al.
Community Dentistry and Oral Epidemiology|October 11, 1991
Periodontal status of individuals in early stages of human immunodeficiency virus infectionC R Drinkard, L Decher, J W Little, et al.
The New England Journal of Medicine|August 17, 1995
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
JAMA|August 10, 1994
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
The New England Journal of Medicine|August 30, 1984
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndromeJ L Ziegler, J A Beckstead, P A Volberding, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|April 15, 1990
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesP A Volberding, S W Lagakos, M A Koch, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
The Journal of Infectious Diseases|April 1, 1986
Serological characterization of HTLV-III infection in AIDS and related disordersJ E Groopman, F W Chen, J A Hope, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complexT L Hodges, J O Kahn, L D Kaplan, et al.
Community Dentistry and Oral Epidemiology|October 11, 1991
Periodontal status of individuals in early stages of human immunodeficiency virus infectionC R Drinkard, L Decher, J W Little, et al.
The New England Journal of Medicine|August 17, 1995
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
JAMA|August 10, 1994
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
The New England Journal of Medicine|August 30, 1984
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndromeJ L Ziegler, J A Beckstead, P A Volberding, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
Pageof 11